Takuma Kato

22PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersMedical genetics (excl. cancer genetics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 18, 2026
Association Between Early Perioperative Fentanyl Exposure and Dose-Normalized Tacrolimus Exposure After Kidney Transplantation.

|Sep 14, 2026
The Complementary Roles of the Prostate Health Index and Multiparametric Magnetic Resonance Imaging in Optimizing the Detection of Clinically Significant Prostate Cancer in Patients With Prostate-Specific Antigen Levels Below 10 Ng/mL.

|Aug 28, 2026
Darolutamide-based triplet therapy versus androgen receptor pathway inhibitor-based doublet therapy for metastatic castration-sensitive prostate cancer: a real-world analysis using the TriNetX database.

|Aug 07, 2026
Prognostic impact of regional lymph node metastasis at castration-resistant prostate cancer diagnosis on survival after radium-223 treatment.

|Jun 26, 2026
Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401.

|Mar 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel.

Takuma Kato, Yoichiro Tohi, Atsushi Takamoto

Pageof 4

Frequent Collaborators

12 joint publications

Yoichiro Tohi

11 joint publications

Mikio Sugimoto

6 joint publications

Rikiya Taoka

4 joint publications

Hirohito Naito